{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:30:52Z","timestamp":1773480652998,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/ico.0b013e31825e83f4","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T12:15:35Z","timestamp":1349007335000},"page":"345-354","source":"Crossref","is-referenced-by-count":65,"title":["Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits"],"prefix":"10.1097","volume":"32","author":[{"given":"Philippe","family":"Daull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lallemand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Buggage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-S\u00e9bastien","family":"Garrigue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210204","first-page":"65","article-title":"2007 report of the international Dry Eye WorkShop (DEWS).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R2-21-20210204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0181-5512(07)89584-2","article-title":"A new approach for better comprehension of diseases of the ocular surface in French.","volume":"30","author":"Baudouin","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"R3-21-20210204","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/08820538.2010.488568","article-title":". Dry eye disease.","volume":"25","author":"Tavares Fde","year":"2010","journal-title":"Semin Ophthalmol"},{"key":"R4-21-20210204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14740338.7.1.79","article-title":"Uses and safety profile of ciclosporin in ophthalmology.","volume":"7","author":"Kashani","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"R5-21-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis.","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye (Lond)"},{"key":"R6-21-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00003226-200203000-00006","article-title":". Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis.","volume":"21","author":"Perry","year":"2002","journal-title":"Cornea"},{"key":"R7-21-20210204","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","article-title":". Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.","volume":"89","author":"Fruman","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-21-20210204","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2165\/00003495-199550050-00009","article-title":"Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).","volume":"50","author":"Noble","year":"1995","journal-title":"Drugs"},{"key":"R9-21-20210204","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R10-21-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses.","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R11-21-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-27492008000700017","article-title":"Rationale for anti-inflammatory therapy in dry eye syndrome.","volume":"71","author":"De Paiva","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"R12-21-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A.","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"R13-21-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000267160","article-title":". A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.","volume":"24","author":"Muchtar","year":"1992","journal-title":"Ophthalmic Res"},{"key":"R14-21-20210204","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/jop.1994.10.509","article-title":"Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits.","volume":"10","author":"Naveh","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"R16-21-20210204","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/978-1-4615-5359-5_144","article-title":". Cyclosporine distribution into the conjunctiva, cornea, lacrimal gland, and systemic blood following topical dosing of cyclosporine to rabbit, dog, and human eyes.","volume":"438","author":"Acheampong","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R17-21-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":". Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr Eye Res"},{"key":"R18-21-20210204","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/088532829701100305","article-title":". The formulation of drug for ocular administration.","volume":"11","author":"Aiache","year":"1997","journal-title":"J Biomater Appl"},{"key":"R19-21-20210204","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10719-008-9136-6","article-title":". Glycan structures of ocular surface mucins in man, rabbit and dog display species differences.","volume":"25","author":"Royle","year":"2008","journal-title":"Glycoconj J"},{"key":"R20-21-20210204","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/10611860400015910","article-title":". Cationic vectors in ocular drug delivery.","volume":"12","author":"Rabinovich-Guilatt","year":"2004","journal-title":"J Drug Target"},{"key":"R21-21-20210204","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/PDT-100102035","article-title":"Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution.","volume":"5","author":"Klang","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"R22-21-20210204","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/02713689008997579","article-title":". Corneal and conjunctivalscleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.","volume":"9","author":"Chien","year":"1990","journal-title":"Curr Eye Res"},{"key":"R23-21-20210204","first-page":"421","article-title":". Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion.","volume":"11","author":"Tamilvanan","year":"2001","journal-title":"STP Pharma Sci"},{"key":"R24-21-20210204","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":". Cyclosporine A delivery to the eye: a pharmaceutical challenge.","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"R25-21-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2004.03.033","article-title":"The potential of lipid emulsion for ocular delivery of lipophilic drugs.","volume":"58","author":"Tamilvanan","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"R27-21-20210204","first-page":"313","article-title":". Tissue concentration of nanoencapsulated radio-labelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits.","volume":"42","author":"Bonduelle","year":"1996","journal-title":"Eur J Pharm Biopharm"},{"key":"R28-21-20210204","first-page":"101","article-title":". Validation of quantitative analytical procedure, Harmonization of approaches.","volume":"13","author":"Hubert","year":"2003","journal-title":"STP Pharma Pratiques"},{"key":"R29-21-20210204","first-page":"2251","article-title":"A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.","volume":"34","author":"Grass","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-21-20210204","first-page":"427","article-title":". Ocular delivery of cyclosporin A. II. Effect of submicron emulsions surface charge on ocular distribution of topical cyclosporin A.","volume":"11","author":"Abdulrazik","year":"2001","journal-title":"STP Pharma Sci"},{"key":"R31-21-20210204","first-page":"S166","article-title":"Ocular retention time of submicron emulsion (SME) and the miotic response to pilocarpine delivered in SME.","volume":"32","author":"Beilin","year":"1995","journal-title":"Invest Opthalmol Vis Sci"},{"key":"R32-21-20210204","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R33-21-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.exer.2010.07.008","article-title":". Immune response in the conjunctival epithelium of patients with dry eye.","volume":"91","author":"Barabino","year":"2010","journal-title":"Exp Eye Res"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31825e83f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:34:15Z","timestamp":1621884855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201303000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31825e83f4","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}